North America Western Blotting Market Trends, Size, Segment and Growth by Forecast to 2023-2030
North America Western Blotting Market Projected to Reach $404.96 Million by 2027, Growing at a 5.4% CAGR
The North
America western blotting market, valued at $257.05 million in 2018, is
anticipated to grow to $404.96 million by 2027, registering a compound annual
growth rate (CAGR) of 5.4% from 2019 to 2027. Key drivers of this growth
include increasing investments in proteomic research and the rising prevalence
of diseases such as Lyme and HIV. However, the adoption of alternative protein
detection technologies may restrain market expansion in the region.
๐Download Full PDF Sample
Copy of Market Report @
https://wwcw.businessmarketinsights.com/sample/TIPRE00006462
Key Market Drivers
1. Rising Prevalence of Lyme Disease
Western blotting plays a crucial role in diagnostic testing,
particularly for Lyme disease, a tick-borne illness increasingly prevalent in
North America. A 2018 study by Carnegie Mellon University highlighted that
climate change is contributing to the growing incidence of Lyme disease in the
U.S. Western blot IgM testing has demonstrated high specificity (94-96%) in
patients exhibiting clinical symptoms of Lyme disease, reinforcing its
diagnostic importance.
2. Increasing HIV/AIDS Cases
The global rise in HIV/AIDS cases has further propelled the
demand for western blotting. HIV, which leads to acquired immunodeficiency
syndrome (AIDS), severely compromises the immune system. According to the U.S.
Department of Health & Human Services, approximately 36.9 million people
worldwide were living with HIV/AIDS in 2017, with a significant burden in low-
and middle-income countries.
In the U.S., around 38,700 new HIV infections were reported
in 2016 (HIV.gov). Western blotting remains a gold-standard confirmatory test
for HIV, following initial ELISA screening. This diagnostic necessity is
expected to sustain market growth in the coming years.
Market Challenges
The adoption of alternative protein detection technologies,
such as mass spectrometry and ELISA-based assays, may hinder the growth of the
western blotting market. These methods offer faster and more automated
solutions, posing competition to traditional western blotting techniques.
Regional Market Outlook
The U.S. is poised to dominate the North
American western blotting market, driven by advancements in biotechnology,
robust R&D activities in diagnostics, and the country's leadership in
biotech-derived agricultural exports. These factors position the U.S. as the
largest contributor to regional market growth during the forecast period.
North America Western Blotting Strategic Insights
Strategic insights for the North America Western Blotting
provides data-driven analysis of the industry landscape, including current
trends, key players, and regional nuances. These insights offer actionable
recommendations, enabling readers to differentiate themselves from competitors
by identifying untapped segments or developing unique value propositions.
Leveraging data analytics, these insights help industry players anticipate the
market shifts, whether investors, manufacturers, or other stakeholders. A
future-oriented perspective is essential, helping stakeholders anticipate
market shifts and position themselves for long-term success in this dynamic
region. Ultimately, effective strategic insights empower readers to make
informed decisions that drive profitability and achieve their business
objectives within the market.
key company profiles
Thermo Fisher Scientific Inc.
Merck KGaA,
GENERAL ELECTRIC
Cell Signaling
Technology, Inc.
PerkinElmer, Inc.
Bio-Rad
Laboratories, Inc.
LI-COR, Inc.
OriGene
Technologies, Inc.,
Rockland
Immunochemicals Inc.
Abcam plc
Regional Insights on Western Blotting in North America
The geographic scope of Western Blotting in North America
encompasses the specific regions where businesses operate and compete.
Recognizing regional differences—such as varying customer needs (e.g.,
preferred equipment specifications or technical requirements), economic
factors, and regulatory standards—is essential for customizing strategies to
local markets. Companies can enhance their market presence by pinpointing
underserved regions or modifying their products and services to align with
regional demands. A well-defined regional focus enables more efficient resource
allocation, tailored marketing efforts, and stronger competitive positioning,
ultimately fostering growth in targeted areas.
About Us:
Business Market Insights is a market research platform that provides subscription service for industry and company reports. Our research team has extensive professional expertise in domains such as Electronics & Semiconductor; Aerospace & Dรฉfense; Automotive & Transportation; Energy & Power; Healthcare; Manufacturing & Construction; Food & Beverages; Chemicals & Materials; and Technology, Media, & Telecommunications
Author's Bio
Akshay
Senior Market Research Expert at Business Market Insights
Comments
Post a Comment